Jessica Federer - Mar 15, 2023 Form 3 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role
Director
Signature
/s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Jessica J. Federer
Stock symbol
SAGE
Transactions as of
Mar 15, 2023
Transactions value $
$0
Form type
3
Date filed
3/17/2023, 04:10 PM
Next filing
Mar 17, 2023

No securities are beneficially owned.